MARC JOSEPH GURWITH
Medical Practice in Los Altos, CA

License number
Pennsylvania MD031400E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address 2
Los Altos, CA 94022
Pennsylvania

Professional information

Marc Gurwith Photo 1

Treatment Of Sle With Dehydroepiandrosterone

US Patent:
6552010, Apr 22, 2003
Filed:
Nov 10, 2000
Appl. No.:
09/710754
Inventors:
Kenneth E. Schwartz - San Mateo CA
Marc J. Gurwith - Los Altos CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 3156
US Classification:
514177, 514170, 514171
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.


Marc Gurwith Photo 2

Dhea Composition And Method

US Patent:
7045513, May 16, 2006
Filed:
Mar 16, 2000
Appl. No.:
09/526802
Inventors:
Jagdish Parasrampuria - Bridgewater NJ, US
Maxine B. Yonker - Emerald Hills CA, US
Kenneth E. Schwartz - San Mateo CA, US
Marc J. Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/56
US Classification:
514170, 514169, 514177, 514178, 514180
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.


Marc Gurwith Photo 3

Dhea Composition And Method

US Patent:
2006023, Oct 19, 2006
Filed:
Mar 21, 2006
Appl. No.:
11/387111
Inventors:
Jagdish Parasrampuria - Bedminster NJ, US
Maxine Yonker - Emerald Hills CA, US
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
International Classification:
A61K 31/57
US Classification:
514177000
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.


Marc Gurwith Photo 4

Treatment Of Sle With Dehydroepiandrosterone

US Patent:
2003018, Sep 25, 2003
Filed:
Jan 8, 2003
Appl. No.:
10/340267
Inventors:
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc.
International Classification:
A61K031/57
US Classification:
514/178000
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.